ArticleBMC medical research methodology2021
Patient-centered practices for engaging transgender and gender diverse patients in clinical research studies.
Article in BMC medical research methodology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 42 citations in OpenAlex.
- Perceived safety and trust shape transgender and gender diverse participation in exercise science: a consensual qualitative research study.Frontiers in sports and active living · 2026Article
- Focus groups as a tool for enhancing pride and community connectedness among transgender and gender diverse research participants.International journal of transgender health · 2026Article
- Gender-Affirming Surgical History, Satisfaction, and Unmet Needs Among Transgender Adults.JAMA network open · 2025Article
- Multifarious approaches of implementation to transfer gender sensitivity in health care practice: a scoping review.BMC health services research · 2025Article
- Critically appraising the cass report: methodological flaws and unsupported claims.BMC medical research methodology · 2025Article
- Observational
- Gender-Affirming Hormone Therapy and Depressive Symptoms Among Transgender Adults.JAMA network open · 2025Observational
- Feasibility and acceptability of collecting biobehavioral data from Latinx transgender and nonbinary people.International journal of transgender health · 2025Article
- Psychosocial influences on pain in transgender individuals.Frontiers in pain research (Lausanne, Switzerland) · 2025Review
- Transgender Individuals' Perspectives on Teledermatology-Based Acne Research.Archives of dermatological research · 2025Article
- Confirmatory validation of the transgender health care humanization scale.International journal for equity in health · 2024Article
- Recruitment tools for transgender and gender diverse veterans in health care research.Psychological services · 2024Article
- Clinical pharmacology in adolescent transgender medicine.British journal of clinical pharmacology · 2024Review
- Decreased Anogenital Gonorrhea and Chlamydia in Transgender and Gender Diverse Primary Care Patients Receiving Gender-Affirming Hormone Therapy.Journal of general internal medicine · 2024Article
- HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.Journal of the International AIDS Society · 2024Article
- HIV Prevention Research Experiences Among Men Who Have Sex With Men and Transgender Persons of Color.Journal of racial and ethnic health disparities · 2023Article
- Examining how study teams manage different viewpoints and priorities in patient-centered outcomes research: Results of an embedded multiple case study.Health expectations : an international journal of public participation in health care and health policy · 2023Article
- Addressing Barriers to Clinical Trial Participation for Transgender People With Cancer to Improve Access and Generate Data.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023Article
- Inclusion of Transgender and Gender Diverse People in Phase III Trials: Examples from HIV Pharmacologic Prevention Studies.Clinical pharmacology and therapeutics · 2023Review
- Clinical Pharmacological Considerations in Transgender Medicine.Handbook of experimental pharmacology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe purpose of this formative study was to assess barriers and facilitators to participation of transgender and gender diverse (TGD) patients in clinical research to solicit specific feedback on perceived acceptability and feasibility of research methods to inform creation of a multisite longitudinal cohort of primary care patients engaged in care at two community health centers.
methodBetween September-November 2018, four focus groups (FGs) were convened at two community health centers in Boston, MA and New York, NY (N = 28 participants across all 4 groups; 11 in Boston and 17 in New York). FG guides asked about patient outreach, acceptability of study methods and measures, and ideas for study retention. FGs were facilitated by TGD study staff, lasted approximately 90 min in duration, were audio recorded, and then transcribed verbatim by a professional transcription service. Thematic analyses were conducted by two independent analysts applying a constant comparison method. Consistency and consensus were achieved across code creation and application aided by Dedoose software.
resultsParticipants were a mean age of 33.9 years (SD 12.3; Range 18-66). Participants varied in gender identity with 4 (14.3%) men, 3 (10.7%) women, 8 (28.6%) transgender men, 10 (35.7%) transgender women, and 3 (10.7%) nonbinary. Eight (26.6%) were Latinx, 5 (17.9%) Black, 3 (10.7%) Asian, 3 (10.7%) another race, and 5 (17.9%) multiracial. Motivators and facilitators to participation were: research creating community, research led by TGD staff, compensation, research integrated into healthcare, research applicable to TGD and non-TGD people, and research helping TGD communities. Barriers were: being research/healthcare averse, not identifying as TGD, overlooking questioning individuals, research coming from a 'cisgender lens", distrust of how the research will be used, research not being accessible to TGD people, and research being exploitative.
conclusionThough similarities emerged between the perspectives of TGD people and research citing perspectives of other underserved populations, there are barriers and facilitators to research which are unique to TGD populations. It is important for TGD people to be involved as collaborators in all aspects of research that concerns them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.